staceywhite, Author at European Medical Journal - Page 126 of 194

Arrhythmogenic Cardiomyopathy: Genetic Pathology, Inflammatory Syndrome, or both?

Arrhythmogenic cardiomyopathy (ACM) affects mainly young athletes <35 years old and has a potential risk of malignant arrhythmias and sudden death.

Cardiac Cachexia Syndrome

This review gathers evidence to enable recognition of cardiac cachexia and improve identification of patients with terminal heart failure.

Fire Ant Venom: A New Compound Discovered for Psoriasis Treatment

NTRIGUING new research has found that specific compounds present in fire ant venom have the potential to form a new, topical treatment for psoriasis…

Advanced Stage III Melanoma: Brand New Adjuvant Therapy Discovered

A NOVEL combination of dabrafenib and trametinib has proven a successful adjuvant therapy for Stage III BRAF-mutant melanoma patients, doubling…

Studying Protein Networks in Bowel Cancer

PROTEOMIC study of bowel cancer cells identifies common protein mutations and allows the prediction of treatment response….

Role of Gut Bacteria as a Parkinson’s Disease Biomarker

BACTERIAL communities in the gut of Parkinson’s patients differ to those of healthy people, potentially providing an early indicator of the…

Liver Disease: A Potential Protective Treatment Opportunity

PROTECTION against alcoholic liver disease may become possible thanks to new research surrounding the protein fibroblast growth factor 21 (FGF21). A…

New Therapeutic Target for Liver Cancer Revealed

PIONEERING research from the University of Maryland, Baltimore, Maryland, USA, has found a potential link between a relatively under-studied gene and…

Urinary Tract Infection Resistant Mutation Identified

A MUTATION altering the effect that levofloxacin, a quinolone antibiotic, has on pathogens causing urinary tract infections (UTI) has been identified by…

Immunotherapy to Advance Prostate Cancer Treatment

A NOVEL immunotherapy strategy for the treatment of prostate cancer using DNA-encoded monoclonal antibodies (DMAb) has shown promising results according…